Adrenal crisis

Adrenal crisis is an endocrine emergency caused by an acute or critically inadequate deficiency of cortisol relative to the body's requirements, typically during infection, trauma, surgery or any form of systemic stress. The result is a collapse of the body's ability to maintain hemodynamic stability, fluid and electrolyte homeostasis and the metabolic response to stress, with possible rapid progression to shock, hypoglycemia and neurological abnormalities. In clinical practice, adrenal crisis is more accurately understood as a condition in which inadequate glucocorticoid availability becomes the determining cause of instability, even when the initial symptoms are nonspecific.

Adrenal crisis may occur in people with known adrenal insufficiency, in individuals with previously undiagnosed adrenal insufficiency or in patients with suppression of the hypothalamic-pituitary-adrenal axis, for example during reduction or withdrawal of glucocorticoid treatment. The distinction between primary and central forms affects some biochemical features, but it does not change the fundamental rule: when clinical suspicion is substantial, treatment with hydrocortisone and fluids must not be delayed while awaiting diagnostic confirmation, because treatment is life-saving and the therapeutic window may be short.

The epidemiology of adrenal crisis is closely related to the prevalence of adrenal insufficiency and the quality of preventive care. In people with known adrenal insufficiency, adrenal crisis is one of the main causes of emergency department attendance and hospitalization, with its frequency influenced by comorbidities, adherence to replacement therapy, availability of emergency kits and the ability to apply dose-increase rules correctly during stress. Adrenal crisis is therefore an event that directly reflects continuity of care, clarity of instructions and the organization of emergency pathways.

The main precipitating factors are febrile infections, gastroenteritis with vomiting or diarrhea, surgery or invasive procedures without adequate glucocorticoid coverage, trauma, sepsis and any condition that reduces oral absorption or abruptly increases cortisol requirements. In crises associated with vomiting, the mechanism is often twofold: interruption of glucocorticoid intake and rapid dehydration with a reduction in effective circulating volume, which amplifies hypotension and accelerates progression to shock.

An increasingly important epidemiological group consists of patients with iatrogenic axis suppression after glucocorticoid exposure. In these individuals, adrenal crisis may be the first clinically significant manifestation, particularly during tapering or after withdrawal, when axis reserve has not yet recovered. This scenario is especially common in respiratory medicine, rheumatology and gastroenterology, where glucocorticoid treatment may be intermittent but prolonged and is often associated with inflammatory exacerbations that independently increase cortisol requirements.

Adrenal crisis is also a significant risk in pituitary and hypothalamic disorders. An ACTH deficiency reduces the adrenal glands' ability to respond to stress and may precipitate instability during infections or surgery, particularly after sellar surgery or radiotherapy. In hypothalamic disorders, vulnerability is related to reduced central drive, as may occur with CRH deficiency or in conditions that globally impair neuroendocrine regulation, with a higher risk when other hormonal deficiencies coexist and reduce clinical resilience.

The likelihood of adrenal crisis is higher in children, older adults and patients with multiple comorbidities because cardiovascular and metabolic reserves are reduced and hypoglycemia or hypotension become more clinically dangerous. Social and healthcare vulnerability also increases risk because adrenal crisis is often preventable through simple interventions, but prevention depends on the ability to recognize symptoms early and obtain rapid access to parenteral hydrocortisone and fluids.

Finally, the risk is influenced by treatment errors and care transitions. Missed doses, poor medication availability, failure to prescribe an emergency kit, absence of recognizable medical documentation and misunderstandings during hospitalization or procedures are preventable systemic factors. The epidemiology of adrenal crisis is therefore also an indicator of healthcare quality, rather than merely a feature of the underlying disease.

Adrenal crisis is the acute and critical form of glucocorticoid insufficiency in which the body does not have enough cortisol to sustain adaptation to stress. Under physiological conditions, cortisol maintains vascular responsiveness to catecholamines, supports cardiac function, stabilizes vascular permeability, ensures adequate glucose metabolism and modulates the inflammatory response. When cortisol is deficient, the stress response becomes ineffective and, paradoxically, excessively reactive from an inflammatory perspective, with possible rapid progression to vasodilation, refractory hypotension and shock.

From an etiological perspective, adrenal crisis occurs in three main settings. The first is untreated or inadequately treated primary adrenal insufficiency, in which cortisol deficiency is often accompanied by aldosterone deficiency, with an increased tendency toward dehydration, hyponatremia and hyperkalemia. The second is central adrenal insufficiency, in which the underlying problem is reduced stimulation by ACTH and the deficiency mainly affects cortisol, while aldosterone is generally preserved. The third is iatrogenic suppression of the axis following exposure to exogenous glucocorticoids, in which the ability to produce cortisol is not available when demand increases.

The hemodynamic pathophysiology is dominated by the loss of glucocorticoid support for vascular tone. During stress, catecholamines and angiotensin II attempt to maintain blood pressure, but without cortisol the vascular response is reduced and vasodilation becomes more pronounced. Capillary permeability may increase, causing a further reduction in effective circulating volume. This mechanism explains why hypotension may be disproportionate and sometimes poorly responsive to fluids alone until hydrocortisone is administered.

At the metabolic level, cortisol is essential for gluconeogenesis and for making energy substrates available during stress and infection. Cortisol deficiency promotes hypoglycemia, particularly in children, older adults, patients with reduced nutritional reserves and people receiving treatment for diabetes, and contributes to confusion, lethargy and neurological risk. Adrenal crisis may also include nausea, vomiting and abdominal pain, which worsen dehydration and interrupt oral treatment, creating a cycle of progressive deterioration.

Fluid and electrolyte abnormalities depend on the type of adrenal insufficiency. In primary adrenal crisis, the absence of aldosterone increases renal sodium loss and potassium retention, worsening hypotension and the risk of arrhythmias. In central adrenal crisis, hyperkalemia is less typical, but hyponatremia may still be substantial because of inappropriate antidiuretic hormone secretion and reduced effective filtration, producing a pattern that may resemble other causes of acute hyponatremia. This distinction helps with differential diagnosis but must not delay treatment, because adrenal crisis is defined by clinical instability rather than by any single electrolyte abnormality.

Finally, a crucial pathophysiological element is the relationship between the replacement dose and the body's requirements. A clinically stable patient receiving regular therapy may remain compensated at rest, but when fever or infection rapidly increases cortisol demand, the baseline dose becomes inadequate. Adrenal crisis is therefore often the result of a failure to increase treatment during stress or an inability to take medication orally, rather than failure of treatment under baseline conditions.

Adrenal crisis presents along a continuum ranging from nonspecific initial symptoms to overt hemodynamic instability. Patients often report a rapid deterioration in energy, nausea and general malaise over a period of hours or days, sometimes preceded by a precipitating event such as a respiratory infection, gastroenteritis or a medical procedure. Fatigue becomes severe, with reduced ability to remain standing and a marked decline in exercise tolerance, followed by dizziness and syncope when orthostatic hypotension develops.

During the medical history, vomiting and diarrhea are common and have a dual significance: they may represent an infectious or inflammatory trigger and also directly cause failure of oral treatment and dehydration. Abdominal pain may be present and, if misinterpreted, may resemble an acute abdomen and contribute to diagnostic delays. In patients with known adrenal insufficiency, there is often a history of failure to increase treatment during fever or an inability to take glucocorticoids because of repeated vomiting.

On physical examination, the main findings are hypotension, tachycardia, signs of dehydration and, in severe cases, altered mental status. The skin may be cold and mottled when peripheral perfusion is impaired. Fever may be present when the crisis has been precipitated by infection, but body temperature may be normal in some cases, making the severity more difficult to recognize. Hyperpigmentation suggests underlying primary adrenal insufficiency, but its absence does not exclude adrenal crisis, particularly in central or iatrogenic forms.

Neurological manifestations include confusion, lethargy and, in the most severe cases, deterioration to coma, often related to prolonged hypotension, hypoglycemia or marked hyponatremia. Adrenal crisis may also present as the sudden worsening of an existing medical condition, with increasing requirements for fluids or vasopressors and an incomplete response until hydrocortisone is administered.

The clinical picture varies according to the type of adrenal insufficiency. In primary forms, aldosterone loss may make dehydration and hyperkalemia more apparent, with cramps and more pronounced weakness. In central forms, the crisis may be more subtle from an electrolyte perspective and may present mainly with hypotension, nausea, fatigue and hypoglycemia, particularly in patients with iatrogenic axis suppression. This profile is typical during glucocorticoid tapering or in patients with pituitary disease and ACTH deficiency, in whom the absence of a stress reserve is the true clinical determinant.

Finally, adrenal crisis is often underdiagnosed because many symptoms may be attributed to sepsis, gastroenteritis or uncomplicated dehydration. The distinguishing feature is the disproportion between the degree of instability and the apparent clinical condition, particularly when risk factors coexist, together with the rapid response to glucocorticoids and fluids when treatment is started early.

Adrenal crisis must be suspected immediately in any patient with known adrenal insufficiency who presents with vomiting, diarrhea, fever, hypotension or altered mental status. In this setting, the clinical principle is that the absence of prompt parenteral treatment can rapidly transform a manageable episode into shock, so the threshold for suspicion must be low. Even an apparently stable patient who is unable to take oral therapy must be considered at high risk because cortisol deficiency can become clinically significant within a few hours.

Suspicion must also be high in patients without a known diagnosis who have relevant risk factors. Prolonged glucocorticoid use, including high-dose inhaled preparations or repeated intra-articular administration, followed by dose reduction or withdrawal, is one of the most frequent settings for unrecognized adrenal crisis. In these cases, the patient may present with severe fatigue, nausea and hypotension during an infection, and the medication history becomes the decisive factor in directing the diagnosis.

Another relevant setting is hypothalamic-pituitary disease. In a person with a sellar lesion, previous pituitary surgery or radiotherapy, or signs of hypopituitarism, acute deterioration with hypotension and hyponatremia should raise the possibility of a central adrenal crisis, consistent with potential ACTH deficiency. Similarly, in hypothalamic disorders or after treatments involving the hypothalamus, reduced central drive, as may occur with CRH deficiency, may impair the stress response and promote decompensation during infections or procedures.

From a clinical perspective, the combination of unexplained hypotension, dehydration, hypoglycemia and hyponatremia, particularly when associated with nausea and vomiting, is highly suggestive. A disproportionate need for vasopressors or an incomplete response to fluids alone is equally important because cortisol deficiency reduces vascular responsiveness. In intensive care or emergency department settings, this presentation should prompt immediate treatment when risk factors are present.

Finally, suspicion must remain high when the presentation resembles sepsis or gastroenteritis but the patient has a compatible history and does not improve as expected. Adrenal crisis may coexist with infection, so the absence of a confirmed infectious focus is not required before treatment. Hydrocortisone does not replace antibiotic treatment when this is indicated, but it may be essential for rapidly stabilizing hemodynamics and metabolism.

The diagnosis of adrenal crisis is primarily clinical and must be made operationally when the presentation is compatible and the pretest probability is significant, because treatment cannot await laboratory confirmation. It is nevertheless useful to obtain blood samples before the first dose of hydrocortisone, when this can be done without causing delay, to measure cortisol, ACTH, sodium, potassium, blood glucose, creatinine and infection markers. These results help define the type of adrenal insufficiency and guide subsequent investigation, but they must never be used as a prerequisite for starting treatment.

Suspected adrenal crisis requires immediate assessment of clinical stability, including blood pressure, heart rate, oxygen saturation, mental status, degree of dehydration and tissue perfusion. Biochemical assessment must include hypoglycemia and hyponatremia because they have immediate therapeutic implications. An electrocardiogram may be useful in the presence of electrolyte abnormalities or instability, while investigation of an infectious or hemorrhagic trigger must proceed simultaneously because the precipitating event is often responsible for the sudden increase in cortisol requirements.

Operational diagnostic approach in an emergency

• Clinical recognition of instability with hypotension, vomiting, neurological abnormalities or dehydration in an at-risk patient, without waiting for confirmation.
• Immediate blood sampling, provided it does not delay treatment, for cortisol and ACTH, together with electrolytes and blood glucose, while simultaneously assessing for infection or other triggers.
• Simultaneous initiation of hydrocortisone and fluids, with frequent clinical reassessment of the hemodynamic and metabolic response.
• Completion of the diagnostic assessment after stabilization, using dynamic testing and etiological investigation, particularly in first-presentation adrenal crisis.

Once the patient has been stabilized, the definitive diagnosis requires confirmation of adrenal insufficiency and identification of its anatomical level. If primary adrenal insufficiency is suspected, elevated ACTH and electrolyte abnormalities support the diagnosis, whereas in central forms ACTH is low or inappropriately normal and aldosterone is generally preserved. However, in an emergency these parameters may be affected by hemodilution, sepsis, prehospital treatment and the timing of sampling, so they must be interpreted cautiously.

In a first-presentation adrenal crisis, the assessment should include adrenal reserve testing when the patient's condition permits and, most importantly, investigation of the underlying cause. In patients with a history of glucocorticoid treatment, axis suppression should be considered a priority. When there are signs of sellar disease or hypopituitarism, assessment must be extended to the other pituitary axes and neuroimaging, consistent with possible ACTH deficiency. If the clinical context suggests hypothalamic involvement, the overall assessment should also consider reduced central drive consistent with CRH deficiency.

The differential diagnosis includes sepsis, hypovolemic shock, pancreatitis, severe gastroenteritis, acute heart failure and other causes of hypotension and electrolyte abnormalities. The key principle is that adrenal crisis often acts as a severity multiplier and may coexist with the precipitating event, so glucocorticoid treatment should be regarded as part of stabilization when relevant risk factors are present.

The classification of adrenal crisis is useful when it helps guide immediate decisions. The first distinction is etiological and separates crises caused by primary adrenal insufficiency from those caused by central or iatrogenic adrenal insufficiency. In primary adrenal insufficiency, aldosterone loss makes severe dehydration and electrolyte imbalance more likely, whereas central forms may be dominated by hypotension and hypoglycemia with less characteristic electrolyte abnormalities. This distinction is more important for risk assessment and subsequent prevention than for the initial intervention, which remains broadly similar.

A second distinction concerns the mode of presentation. Some crises are overt, with shock and altered mental status already present at first contact, whereas others present as progressive decompensation with vomiting, dehydration and hemodynamic deterioration over several hours. In both situations, progression may be rapid and severity must be assessed using clinical parameters rather than the reported intensity of symptoms.

From an operational perspective, it is useful to recognize a pre-crisis phase, typically characterized by acute worsening of fatigue, nausea and orthostatic hypotension, often in a patient with known adrenal insufficiency who has not increased treatment during fever or cannot take oral medication. This phase is particularly important because early administration of hydrocortisone and fluids may prevent shock and reduce the risk of prolonged hospitalization.

Severity also depends on the clinical context. In children, adrenal crisis is more likely to present with hypoglycemia and rapid deterioration, whereas in older adults and patients with heart disease, hypotension and impaired perfusion may precipitate cardiovascular events. In patients with sepsis, adrenal crisis may be overlooked because it overlaps with septic shock, but known adrenal insufficiency or axis suppression makes adequate glucocorticoid coverage essential.

Finally, a useful classification distinguishes a first presentation from a recurrent crisis. A crisis in an undiagnosed patient requires a complete etiological investigation after stabilization, whereas a crisis in a patient with an established diagnosis mainly requires analysis of preventable causes, including stress-dosing errors, absence of an emergency kit, care transitions or failure to inform healthcare professionals before procedures.

Treatment of adrenal crisis must be immediate and standardized because the condition is potentially fatal but often responds rapidly to appropriate treatment. The two main interventions are parenteral hydrocortisone and rehydration with isotonic saline, together with correction of hypoglycemia and treatment of the precipitating trigger, particularly infection. The intervention does not require prior diagnostic confirmation. When clinical suspicion is plausible, failure to treat is more dangerous than empiric administration of hydrocortisone.

Emergency glucocorticoid treatment consists of an initial dose of intravenous or intramuscular hydrocortisone followed by continuous or divided administration during the next 24 hours. The goal is to rapidly achieve a glucocorticoid level sufficient to restore vascular responsiveness and metabolic stability. After the first 24 hours, and once the patient's condition has improved, the dose is progressively reduced until oral replacement therapy can be resumed, while maintaining adequate intermediate coverage during recovery because cortisol requirements remain elevated until the precipitating event has resolved.

Rehydration should be intensive during the initial phase, with isotonic saline infusions guided by blood pressure, heart rate, urine output and cardiac comorbidities. If hypoglycemia is present or the risk is high, intravenous glucose must be administered and blood glucose monitored repeatedly. Correction of hyponatremia must be cautious and guided by its cause, remembering that it often improves with hydrocortisone and restoration of effective circulating volume without the need for inappropriate rapid correction.

Treatment of the precipitating trigger is an integral part of management. If infection is suspected, antibiotics and source control must be initiated simultaneously. If the crisis was precipitated by vomiting, nausea must be controlled and reliable oral absorption restored before discharge, in addition to parenteral treatment. If the crisis occurs in the perioperative period, glucocorticoid coverage must be coordinated with the anesthesia and surgical teams because the aim is to prevent hemodynamic fluctuations and ensure a safe transition to oral therapy.

In primary adrenal insufficiency, mineralocorticoid loss may require reassessment and restoration of specific replacement treatment after stabilization, but during the crisis high-dose hydrocortisone also provides sufficient mineralocorticoid activity in the initial phase. In central and iatrogenic forms, attention is focused on restoring cortisol availability and defining a plan for axis recovery, particularly when the crisis was triggered by glucocorticoid withdrawal without adequate tapering.

A decisive aspect of treatment is the transition to prevention. Before discharge, the patient must receive precise instructions regarding stress dosing, parenteral treatment in the event of vomiting and recognition of early warning signs. Without this step, the risk of recurrence in the following weeks remains high because recovery is a period during which recurrent infections or reduced food intake may reproduce similar conditions.

Follow-up after adrenal crisis has three main objectives: preventing recurrence, establishing or optimizing the diagnosis of adrenal insufficiency and ensuring that the patient can manage future stress safely. In patients with previously diagnosed adrenal insufficiency, follow-up must reconstruct the cause of the event and distinguish an unavoidable trigger from preventable factors such as failure to increase the dose, absence of an emergency kit or delayed access to care. The analysis must be practical and lead to operational corrections because most recurrent crises can be prevented through simple, applicable rules.

In patients presenting with a first adrenal crisis, the priority is to complete the etiological investigation after stabilization. This includes confirmation of the deficiency through dynamic testing when indicated and distinction between primary and central forms using ACTH and comprehensive axis assessment. If findings suggest sellar disease or ACTH deficiency, follow-up must include assessment of the other pituitary axes and neuroimaging. If the clinical context suggests reduced hypothalamic drive consistent with CRH deficiency or functional suppression, the strategy must include a pathway for axis recovery and safety criteria during infections and procedures.

Monitoring of replacement treatment requires attention to signs of both underreplacement and overreplacement. After a crisis, higher doses are often required for several days, followed by gradual reduction to the baseline dose. Clinical assessment should include blood pressure, body weight, gastrointestinal symptoms, sleep quality, energy levels and glycemic control when relevant. The aim is to avoid an excessively rapid return to the baseline dose that could expose the patient to renewed relative insufficiency, while also avoiding excessive exposure that increases metabolic risk.

A crucial element of follow-up is emergency preparedness. The patient should have a written stress-dosing plan, a clear method of obtaining and administering parenteral hydrocortisone in the event of vomiting and a system that allows healthcare professionals to recognize the condition rapidly, such as a medical alert card or clinical document. Periodic reinforcement of education, caregiver involvement and practical verification of the ability to administer intramuscular hydrocortisone, when indicated, significantly reduce the risk of further crises.

Finally, follow-up must include management of comorbidities and the precipitating trigger. In patients with recurrent infections, gastrointestinal disorders or frailty, preventive strategies should be identified and baseline treatment optimized. In patients receiving chronic or intermittent glucocorticoid treatment, every future prescription must consider the risk of axis suppression and include a tapering and reassessment plan because prevention of future crises also depends on appropriate management of treatments that interfere with the axis.

The prognosis of adrenal crisis is generally favorable when treatment is prompt, but it may become severe when therapy is delayed or when sepsis, marked dehydration or cardiovascular comorbidities coexist. The response to hydrocortisone and fluids is often rapid, with recovery of blood pressure and improvement in mental status, and this reversibility makes early recognition particularly important. However, prognosis depends on the time elapsed before glucocorticoid administration and on control of the precipitating event.

The main complications result from prolonged shock and metabolic abnormalities. Persistent hypotension may cause organ injury, acute kidney injury and ischemia, while hypoglycemia may result in neurological complications. Severe hyponatremia may contribute to seizures or deterioration in mental status, particularly when it develops rapidly. These complications are more likely in children, older adults and frail patients, whose physiological reserve is reduced and whose compensatory window is shorter.

Recurrence represents a critical area of complication. Without structured follow-up and practical preventive measures, the patient may experience further crises during subsequent infections, particularly when the previous event was triggered by vomiting and failure to administer parenteral treatment. Recurrence is clinically important because it is often preventable and indicates a failure in the educational or logistical pathway rather than an unavoidable biological event.

Iatrogenic complications, by contrast, may result from prolonged glucocorticoid overreplacement after the crisis or from difficulties returning to the baseline replacement dose. High-dose hydrocortisone is safe and necessary during the emergency, but failure to reduce it appropriately may increase the risk of hyperglycemia, infection and decompensation in patients with heart disease. A correct transition with gradual dose reduction and clinical monitoring limits this risk and improves outcomes.

In the long term, the best prognosis is associated with a robust prevention system based on repeated education, access to emergency kits, clear stress-dosing rules and immediate recognition of the condition throughout healthcare pathways. Adrenal crisis is therefore a treatable emergency whose mortality and morbidity depend primarily on prompt intervention and the quality of the healthcare organization surrounding the patient.